• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基因治疗的当前观点及其在治疗遗传疾病中的应用。

Current perspectives on gene therapy and its involvement in curing genetic disorders.

作者信息

Nishad Shireen, Dongare Dipali, Saha Sayani, Anil Raskar Dhanashri, Srivastava Nidhi, Dey Abhishek

机构信息

Department of Biotechnology, National Institute of Pharmaceutical Education and Research, Bijnor-Sisendi Road, Sarojini Nagar, Near CRPF Base Camp, Lucknow, UP, 226002, India.

出版信息

Hum Genet. 2025 Jun 18. doi: 10.1007/s00439-025-02757-7.

DOI:10.1007/s00439-025-02757-7
PMID:40533637
Abstract

Genomics is revolutionizing medical science, offering transformative potential for the future of medicine. Advances in whole-genome sequencing have deepened our understanding of genome structure and function, paving the way for genomic medicine. The Human Genome Project has been instrumental in identifying genetic variations linked to increased disease risks, such as cancer, enabling genome-based diagnostics and personalized therapeutic strategies. Human genomics research focuses on developing precise therapies to enhance public health and address rare genetic disorders, including Spinal muscular atrophy, Duchenne muscular dystrophy, Parkinson's disease, and Huntington's disease. Cutting-edge gene-editing tools like CRISPR allow precise and targeted modifications with minimal side effects, improving treatment efficacy. By examining the interplay of genetic factors in health and disease, genomics lays the foundation for personalized medicine. This review highlights the impact of genomics on public health and its potential to reshape healthcare through innovative treatment strategies.

摘要

基因组学正在彻底改变医学科学,为医学的未来提供变革潜力。全基因组测序的进展加深了我们对基因组结构和功能的理解,为基因组医学铺平了道路。人类基因组计划在识别与疾病风险增加相关的基因变异(如癌症)方面发挥了重要作用,从而实现基于基因组的诊断和个性化治疗策略。人类基因组学研究专注于开发精确疗法,以改善公众健康并解决罕见遗传疾病,包括脊髓性肌萎缩症、杜氏肌营养不良症、帕金森病和亨廷顿舞蹈症。像CRISPR这样的前沿基因编辑工具能够进行精确且靶向的修饰,副作用极小,从而提高治疗效果。通过研究健康与疾病中遗传因素的相互作用,基因组学为个性化医学奠定了基础。本综述强调了基因组学对公众健康的影响及其通过创新治疗策略重塑医疗保健的潜力。

相似文献

1
Current perspectives on gene therapy and its involvement in curing genetic disorders.基因治疗的当前观点及其在治疗遗传疾病中的应用。
Hum Genet. 2025 Jun 18. doi: 10.1007/s00439-025-02757-7.
2
Unlocking the potential: advancements and applications of gene therapy in severe disorders.释放潜能:基因疗法在严重疾病中的进展与应用
Ann Med. 2025 Dec;57(1):2516697. doi: 10.1080/07853890.2025.2516697. Epub 2025 Jun 17.
3
Genome Editing of Monogenic Neuromuscular Diseases: A Systematic Review.单基因神经肌肉疾病的基因组编辑:系统评价。
JAMA Neurol. 2016 Nov 1;73(11):1349-1355. doi: 10.1001/jamaneurol.2016.3388.
4
Advancing crop disease resistance through genome editing: a promising approach for enhancing agricultural production.通过基因组编辑提升作物抗病性:一种提高农业产量的有前景的方法。
Front Genome Ed. 2024 Jun 26;6:1399051. doi: 10.3389/fgeed.2024.1399051. eCollection 2024.
5
Management of urinary stones by experts in stone disease (ESD 2025).结石病专家对尿路结石的管理(2025年结石病专家共识)
Arch Ital Urol Androl. 2025 Jun 30;97(2):14085. doi: 10.4081/aiua.2025.14085.
6
Unlocking the potential of CRISPR-Cas9 for cystic fibrosis: A systematic literature review.挖掘CRISPR-Cas9治疗囊性纤维化的潜力:一项系统文献综述
Gene. 2025 Mar 20;942:149257. doi: 10.1016/j.gene.2025.149257. Epub 2025 Jan 18.
7
Deep Genomics: Deep Learning-Based Analysis of Genome-Sequenced Data for Identification of Gene Alterations.深度基因组学:基于深度学习的基因组测序数据分析以识别基因改变
Methods Mol Biol. 2025;2952:335-367. doi: 10.1007/978-1-0716-4690-8_20.
8
How to design a national genomic project-a systematic review of active projects.如何设计国家基因组项目——对正在进行的项目的系统评价。
Hum Genomics. 2021 Mar 24;15(1):20. doi: 10.1186/s40246-021-00315-6.
9
Therapeutic Application of mRNA for Genetic Diseases.信使核糖核酸在遗传性疾病中的治疗应用。
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2025 May-Jun;17(3):e70019. doi: 10.1002/wnan.70019.
10
The Use of AI for Phenotype-Genotype Mapping.人工智能在表型-基因型映射中的应用。
Methods Mol Biol. 2025;2952:369-410. doi: 10.1007/978-1-0716-4690-8_21.

本文引用的文献

1
Gene therapy for age-related macular degeneration: a promising frontier in vision preservation.年龄相关性黄斑变性的基因治疗:视力保护的一个有前景的前沿领域。
Cell Commun Signal. 2025 May 20;23(1):233. doi: 10.1186/s12964-025-02246-4.
2
Recent Advances and Prospects in RNA Drug Development.RNA 药物研发的最新进展与展望。
Int J Mol Sci. 2024 Nov 15;25(22):12284. doi: 10.3390/ijms252212284.
3
Revolutionizing healthcare and medicine: The impact of modern technologies for a healthier future-A comprehensive review.变革医疗保健与医学:现代技术对更健康未来的影响——全面综述
Health Care Sci. 2024 Oct 9;3(5):329-349. doi: 10.1002/hcs2.115. eCollection 2024 Oct.
4
Give Cas a Chance: An Actionable Path to a Platform for CRISPR Cures.给卡斯一个机会:通往CRISPR疗法平台的可行之路。
CRISPR J. 2024 Oct;7(5):212-219. doi: 10.1089/crispr.2024.0082.
5
CRISPR/Cas9 in the treatment of sickle cell disease (SCD) and its comparison with traditional treatment approaches: a review.CRISPR/Cas9在镰状细胞病(SCD)治疗中的应用及其与传统治疗方法的比较:综述
Ann Med Surg (Lond). 2024 Aug 14;86(10):5938-5946. doi: 10.1097/MS9.0000000000002478. eCollection 2024 Oct.
6
Genome Editing Therapy for the Blood: Success and Prospects.血液的基因组编辑治疗:成功与前景。
CRISPR J. 2024 Oct;7(5):231-248. doi: 10.1089/crispr.2024.0036. Epub 2024 Sep 26.
7
Regulatory Assessment of Casgevy for the Treatment of Transfusion-Dependent β-Thalassemia and Sickle Cell Disease with Recurrent Vaso-Occlusive Crises.Casgevy用于治疗依赖输血的β地中海贫血和复发性血管闭塞性危象的镰状细胞病的监管评估。
Curr Issues Mol Biol. 2024 Jul 30;46(8):8209-8225. doi: 10.3390/cimb46080485.
8
[Prime-Editing Methods and pegRNA Design Programs].[碱基编辑方法与pegRNA设计程序]
Mol Biol (Mosk). 2024 Jan-Feb;58(1):22-39.
9
The FDA and Gene Therapy for Duchenne Muscular Dystrophy.美国食品药品监督管理局与杜氏肌营养不良症的基因疗法
JAMA. 2024 May 28;331(20):1705-1706. doi: 10.1001/jama.2024.5613.
10
Splice-Modulating Antisense Oligonucleotides as Therapeutics for Inherited Metabolic Diseases.剪接调节反义寡核苷酸作为遗传性代谢疾病的治疗方法。
BioDrugs. 2024 Mar;38(2):177-203. doi: 10.1007/s40259-024-00644-7. Epub 2024 Jan 22.